Table 1.
Characteristic | |
---|---|
Sex [n = 16 026; number missing: 40 (0.2%)] | |
Male | 10 560 (65.9) |
Female | 5448 (34.0) |
Other | 18 (0.1) |
Age at baseline (n = 16 066; number missing: 0) | |
Age (years) [mean (SD)] | 40 (11) |
Mode of HIV acquisition [n = 14 493; number missing: 1573 (9.8%)] | |
Heterosexual | 7571 (52.2) |
MSM | 6091 (42.0) |
IDU | 365 (2.5) |
MTCT | 174 (1.2) |
Other | 292 (2.0) |
Nationality [n = 15 353; number missing: 713 (4.4%)] | |
Belgian | 8209 (53.5) |
SSA | 4488 (29.2) |
European | 1608 (10.5) |
Other | 1048 (6.8) |
Time period of HIV diagnosis [n = 15 349; number missing: 717 (4.5%)] | |
1980–1989 | 678 (4.4) |
1990–1999 | 3010 (19.6) |
2000–2009 | 6655 (43.4) |
2010–2016 | 5006 (32.6) |
Nadir CD4 count [n = 15 938; number missing: 128 (0.8%)] | |
< 350 cells/µL | 8396 (52.7) |
≥ 350 cells/µL | 7542 (47.3) |
ART status [n = 15 237; number missing: 829 (5.2%)] | |
Ever on ART | 14 117 (92.6) |
No ART | 1120 (7.4) |
Systolic blood pressure [n = 9430; number missing: 6636 (41.3%)] | |
High | 2909 (30.8) |
Normal | 6521 (69.2) |
Smoking [n = 8887; number missing: 7179 (44.7%)] | |
Yes | 3472 (39.1) |
No | 5415 (60.9) |
BMI [n = 7565; number missing: 8501 (52.9%)] | |
≥ 30 (obese) | 1151 (15.2) |
< 30 | 6414 (84.8) |
ART, antiretroviral therapy; BMI, body mass index; IDU, injecting drug use; MSM, men who have sex with men; MTCT, mother to child transmission; SD, standard deviation; SSA, sub‐Saharan African.